AstraZeneca accused of cherry-picking vaccine study data
3 years, 9 months ago

AstraZeneca accused of cherry-picking vaccine study data

Associated Press  

WASHINGTON — AstraZeneca may have included “outdated information” in touting the effectiveness of its COVID-19 vaccine in a U.S. study, federal health officials said Tuesday in an unusual public rift that could further erode confidence in the shot. But shortly after midnight, the National Institutes of Health issued a statement saying the independent monitors that oversee the study had “expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data.” The NIH urged the company to “ensure the most accurate, up-to-date efficacy data be made public as quickly as possible.” Outside experts were surprised and puzzled by the spat. But they noted that ultimately the Food and Drug Administration will scrutinize all the data before deciding whether AstraZeneca’s vaccine can be rolled out in the U.S. “It would seem that whatever this communication misstep is, at the end of the day the data will have to stand for itself,” said Dr. Jesse Goodman of Georgetown University, a former FDA vaccine chief. The U.S. study findings announced by AstraZeneca were consistent with studies from elsewhere — and real-world use in Britain — that found the vaccine offers good protection against the worst COVID-19 has to offer.

Vaccine Astrazeneca Nih Its Vaccine Dsmb Study Data  cherrypicking  study  data  health  astrazeneca  vaccine  covid19  accused  public  effectiveness  company  dsmb

History of this topic

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
8 months ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
8 months ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca pulls its COVID-19 vaccine from the European market
8 months ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
8 months ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

COVID-19 vaccines: Much ado about known unknowns
8 months ago

COVID-19 vaccines: Much ado about known unknowns

The Hindu  

There are things we know that we don’t know. This risk was identified and flagged back in 2021; packaging was modified to insert information associated with the side effects; even the WHO wrote about it first in May 2021 and then in 2023.Read Bindu Shajan Perapaddan’s report on the rare vaccine side-effect is “no secret” and they are “well aware …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
8 months, 1 week ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?
8 months, 1 week ago

AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?

Hindustan Times  

Pharmaceutical giant AstraZeneca has accepted for the first time that its Covid vaccine “can, in very rare cases, cause TTS”. {{^usCountry}} {{/usCountry}} AstraZeneca has been fighting a class action lawsuit that alleges its Covid vaccine, which was developed with the help of University of Oxford, has led to several deaths and serious injury. {{^userSubscribed}} {{/userSubscribed}} {{^userSubscribed}} {{/userSubscribed}} Responding to Scott's …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 8 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

AstraZeneca set to abandon push for US vaccine approval
2 years, 9 months ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment
3 years, 3 months ago

AstraZeneca Asks FDA to Authorise Covid Antibody Treatment

News 18  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca asks FDA to authorise COVID antibody treatment
3 years, 3 months ago

AstraZeneca asks FDA to authorise COVID antibody treatment

The Hindu  

AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorise the emergency use of an antibody treatment to prevent the disease. The company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. The …

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial
3 years, 3 months ago

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial

India Today  

AstraZeneca Plc's Covid-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company's US clinical trial published on Wednesday. Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later …

AstraZeneca tests Covid booster shots against Beta-variant
3 years, 6 months ago

AstraZeneca tests Covid booster shots against Beta-variant

India TV News  

British-Swedish biopharmaceutical firm AstraZeneca has in partnership with the University of Oxford rolled out human trials for booster shots against Beta Covid variant. The booster shot, named AZD2816, will be administered to individuals who have previously been fully vaccinated with two doses of AstraZeneca vaccine/Vaxzervia or an mRNA vaccine, at least three months after their last injection. AZD2816 has been …

AstraZeneca Tests Modified Booster Jab Against Beta Variant of Covid-19
3 years, 6 months ago

AstraZeneca Tests Modified Booster Jab Against Beta Variant of Covid-19

News 18  

AstraZeneca and the University of Oxford on Sunday began new trials to test a modified vaccine against the Beta variant, which first emerged in South Africa. The new vaccine, known as AZD2816, has been designed using the same base as the main AstraZeneca shot but with minor genetic alterations to the spike protein based on the Beta variant. “Testing booster …

Rise in Delta variant cases worry UK residents, experts hopeful of AstraZeneca vaccine
3 years, 6 months ago

Rise in Delta variant cases worry UK residents, experts hopeful of AstraZeneca vaccine

India Today  

Real-world data from Public Health England comes as a reassurance against the Delta variant as the number of Covid-19 cases rises in the UK, leading experts to fear the third wave. New real-world data from Public Health England has shown that two doses of AstraZeneca is 92 per cent effective against hospitalisation due to the Delta variant. Mene Pangalos, Executive …

We didn’t back govt move to double vaccine dosing gap: scientists
3 years, 6 months ago

We didn’t back govt move to double vaccine dosing gap: scientists

Live Mint  

NEW DELHI : The Indian government doubled the gap between the two doses of the AstraZeneca COVID-19 vaccine without the agreement of the scientific group that it said recommended the increase, three members of the advisory body told Reuters. Gupte, a former director of the state-run National Institute of Epidemiology, said the NTAGI had backed increasing the dosing interval to …

Covid-19 Vaccine: EU Advises Adding Condition to AstraZeneca Label
3 years, 6 months ago

Covid-19 Vaccine: EU Advises Adding Condition to AstraZeneca Label

News 18  

The European Medicines Agency says it's recommending that people who have had a rare blood vessel syndrome not be immunised with AstraZeneca's Covid-19 vaccine. In a statement on Friday, the EU drug regulator said it reviewed cases of six people who had capillary leak syndrome after they had received a shot of the AstraZeneca vaccine. EMA experts also concluded that …

Britain Seeks Extra AstraZeneca Shots to Combat 'Beta' Covid-19 Variant
3 years, 7 months ago

Britain Seeks Extra AstraZeneca Shots to Combat 'Beta' Covid-19 Variant

News 18  

Britain is in talks with Oxford and AstraZeneca for additional doses of their COVID-19 vaccine that has been modified to better target the “beta” coronavirus variant first identified in South Africa, and it will fund trials of the shots. Britain has previously secured 100 million doses of the vaccine, developed at the University of Oxford and licenced to AstraZeneca, and …

Covid vaccines available faster for some as at-risk people not booking appointments
3 years, 7 months ago

Covid vaccines available faster for some as at-risk people not booking appointments

NL Times  

More than a half of people under the age of 60 from groups at a higher risk should the get the SARS-CoV-2 coronavirus infection have not yet requested an appointment to get their early Covid-19 vaccine shots. Consequently, new advice regarding the use of the AstraZeneca vaccine with this age group may arrive too late to have an impact. Additionally, …

Healthcare inspectorate releases AstraZeneca advice at odds with gov’t; Quickly taken offline
3 years, 8 months ago

Healthcare inspectorate releases AstraZeneca advice at odds with gov’t; Quickly taken offline

NL Times  

The Healthcare Inspectorate published an advisory statement on its website on Tuesday which said that doctors must be able to make a professional assessment when patients younger than 60 request to be given the AstraZeneca Covid-19 vaccine for urgent medical reasons. That conflicted with the government’s decision to completely stop using the jab for under-60s, a decision which Health Minister …

Over-60s less willing to get AstraZeneca Covid vaccine; Many no-shows at GP jab appointments
3 years, 8 months ago

Over-60s less willing to get AstraZeneca Covid vaccine; Many no-shows at GP jab appointments

NL Times  

More than 40 percent of people over 60 said they are no longer interested in receiving the AstraZeneca Covid-19 vaccine, NOS reported based on their research. Some 58 percent of the Dutch people surveyed said they would also like to be able to decide which shot they are being given, as opposed to the Cabinet determining their eligibility No-shows for …

Karl Stefanovic says he is nervous about AstraZeneca Covid jab and prefers to wait for alternative
3 years, 8 months ago

Karl Stefanovic says he is nervous about AstraZeneca Covid jab and prefers to wait for alternative

Daily Mail  

Today host Karl Stefanovic has revealed he is 'nervous' about receiving the AstraZeneca Covid-19 vaccine after blood clot fears led to the government advising those aged under 50 not to get that particular jab. Stefanovic, 46, said on Monday he would preference waiting for an alternative vaccine such as Pfizer over being administered doses of the AstraZeneca jab, when speaking …

After AstraZeneca concerns, how can Australia reclaim public confidence in the vaccine rollout?
3 years, 9 months ago

After AstraZeneca concerns, how can Australia reclaim public confidence in the vaccine rollout?

ABC  

Health authorities concede the decision to offer people under 50 an alternative vaccine to the AstraZeneca shot will impact confidence in the vaccine rollout. Chief Medical Officer Professor Paul Kelly said health authorities had been as forthcoming as possible about decisions to change which vaccine people would get. Leading vaccine communication expert Professor Julie Leask, from the University of Sydney, …

WHO chief laments 'shocking imbalance' in Covid-19 shot distribution
3 years, 9 months ago

WHO chief laments 'shocking imbalance' in Covid-19 shot distribution

Hindustan Times  

There is a "shocking imbalance" in the distribution of Covid-19 vaccines worldwide and most countries do not have anywhere near enough shots to cover health workers and others at high-risk, WHO Director-General Tedros Adhanom Ghebreyesus said on Friday. The COVAX facility has delivered nearly 38.4 million doses of Covid-19 vaccines to 102 countries across six continents, six weeks after it …

Government vaccine advisors say they don’t foresee AstraZeneca vaccine being used in the US
3 years, 9 months ago

Government vaccine advisors say they don’t foresee AstraZeneca vaccine being used in the US

CNN  

CNN — Vaccine advisers to the federal government tell CNN they don’t foresee AstraZeneca’s Covid-19 vaccine being used in the United States, and even if it were offered, they personally wouldn’t take it, given the other available options. Dr. Anthony Fauci told CNN Wednesday that even if the US Food and Drug Administration granted emergency use authorization to AstraZeneca’s vaccine, …

AstraZeneca woes grow as Australia, Philippines, African Union curb Covid-19 shots
3 years, 9 months ago

AstraZeneca woes grow as Australia, Philippines, African Union curb Covid-19 shots

India Today  

Australia and the Philippines limited use of AstraZeneca's Covid-19 vaccine on Thursday, while the African Union dropped plans to buy the shot amid global shortages, dealing further blows to the company's hopes to deliver a vaccine for the world. The Philippines suspended the use of AstraZeneca shots for people under age 60 after Europe's regulator said on Wednesday it found …

How AstraZeneca’s latest vaccine troubles could slow the global recovery
3 years, 9 months ago

How AstraZeneca’s latest vaccine troubles could slow the global recovery

CNN  

London CNN Business — AstraZeneca’s vaccine is key to ending the global economic slump caused by the coronavirus. The World Health Organization said in a statement Wednesday that “based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed.” AstraZeneca said that nearly 200 million …

AstraZeneca Covid vaccine possibly linked to rare blood clots: EU drug regulator
3 years, 9 months ago

AstraZeneca Covid vaccine possibly linked to rare blood clots: EU drug regulator

Hindustan Times  

The EU’s drug regulator on Wednesday said that the reported cases of blood clotting should be listed as a possible side effect of AstraZeneca's vaccine against the coronavirus disease. Last week, the UK’s medicine regulator confirmed the death of seven individuals from unusual blood clots after they were administered with AstraZeneca vaccine. Several European countries have temporarily suspended the use …

European countries consider mixing COVID-19 vaccines because of AstraZeneca concerns
3 years, 9 months ago

European countries consider mixing COVID-19 vaccines because of AstraZeneca concerns

ABC  

Several European countries are considering mixing COVID-19 vaccines for citizens who received a first dose of AstraZeneca's shot, an unprecedented move highlighting the challenge for governments struggling to tame rising infections. Key points: Concerns over the safety of the AstraZeneca vaccine have led to countries pausing their rollout Some people who received their first COVID-19 shot, are no longer eligible …

AstraZeneca vaccine comes under further pressure in EU, UK
3 years, 9 months ago

AstraZeneca vaccine comes under further pressure in EU, UK

Al Jazeera  

While the EMA says ‘possible link’ found between the jab and ‘unusual’ blood clots, the UK offers young people alternative shot due to risks. The embattled AstraZeneca COVID-19 vaccine came under further pressure on Wednesday, as the European Union’s medicines regulator found a possible link between the shot and rare cases of blood clots, while the United Kingdom announced it …

UK Oxford-AstraZeneca COVID vaccine trial in children paused
3 years, 9 months ago

UK Oxford-AstraZeneca COVID vaccine trial in children paused

Al Jazeera  

Oxford University says there were ‘no safety concerns’ in the trial but will await additional data before restarting. The University of Oxford said on Tuesday it had paused a small UK trial testing the COVID-19 vaccine it developed with AstraZeneca in children and teenagers, as it waits for more data on rare blood clotting issues in adults who received the …

Medical experts urge calm as Therapeutic Goods Administration continues to probe blood-clotting case after AstraZeneca COVID shot
3 years, 9 months ago

Medical experts urge calm as Therapeutic Goods Administration continues to probe blood-clotting case after AstraZeneca COVID shot

ABC  

Medical experts say there is no need to panic as Australia's medical regulator continues to review the case of a man who was hospitalised with blood clots after receiving the AstraZeneca vaccine. Key points: The Therapeutic Goods Administration is meeting to determine whether the man has a very rare form of blood clotting, and whether that is linked to the …

EXPLAINER: What we know about AstraZeneca blood clot reports
3 years, 9 months ago

EXPLAINER: What we know about AstraZeneca blood clot reports

Associated Press  

LONDON — German officials have decided to limit the use of AstraZeneca’s coronavirus vaccine in people under 60 after more unusual blood clots were reported in a small number of people who received the shots. Earlier this week, Germany’s medical regulator released new data showing a rise in reported cases of unusual kinds of blood clots in people who recently …

German cities suspend AstraZeneca vaccine use for under-60s
3 years, 9 months ago

German cities suspend AstraZeneca vaccine use for under-60s

India Today  

Authorities in Berlin and Munich are again suspending the use of AstraZeneca’s coronavirus vaccine for residents under age 60 due to new reports of unusual blood clots in people who recently received the shots, officials said Tuesday. The decision came after the country’s medical regulator announced that it had received a total of 31 reports of rare blood clots in …

AstraZeneca revises COVID-19 vaccine efficacy to 76% after US panel flags issues
3 years, 9 months ago

AstraZeneca revises COVID-19 vaccine efficacy to 76% after US panel flags issues

Firstpost  

The revised figures comes a day after an independent panel in the US accused AstraZeneca of cherry-picking data in determining the protection offered by its vaccine Washington: AstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional illnesses in its disputed US study, the latest in an extraordinary public rift with American officials. Some experts said the …

US health officials say AstraZeneca may have included 'outdated information' in coronavirus vaccine trial
3 years, 9 months ago

US health officials say AstraZeneca may have included 'outdated information' in coronavirus vaccine trial

ABC  

AstraZeneca may have included "outdated information" in touting the effectiveness of its COVID-19 vaccine in a US study, federal health officials have said, in an unusual public rift that could further erode confidence in the shot. Key points: AstraZeneca released the result of a 32,000-person study in the US to measure the effectiveness of its vaccine But an independent panel …

New AstraZeneca report says vaccine was 76% effective in preventing Covid-19 symptoms
3 years, 9 months ago

New AstraZeneca report says vaccine was 76% effective in preventing Covid-19 symptoms

CNN  

CNN — Drug giant AstraZeneca updated its data on how well its coronavirus vaccine works, saying late Wednesday the vaccine showed 76% efficacy against symptomatic coronavirus disease and 100% efficacy against severe or critical disease or the need for hospitalization. On Tuesday, the independent Data and Safety Monitoring Board that reviews data from multiple Covid-19 vaccine candidates expressed concern over …

A top health official warned relaxing Covid-19 measures threatens progress. A day later, more states said they were easing restrictions
3 years, 9 months ago

A top health official warned relaxing Covid-19 measures threatens progress. A day later, more states said they were easing restrictions

CNN  

CNN — The emergence of Covid-19 variants makes reopening efforts in the United States a riskier proposition, an infectious disease expert said Wednesday. A month ago, the seven-day average was about 1.5 million doses per day, according to a CNN analysis of CDC data. Philadelphia cancels at least 11,000 invalid vaccine appointments Philadelphia canceled thousands of Covid-19 vaccine appointments at …

AstraZeneca lowers COVID-19 vaccine efficacy slightly to 76% after U.S. criticism
3 years, 9 months ago

AstraZeneca lowers COVID-19 vaccine efficacy slightly to 76% after U.S. criticism

LA Times  

AstraZeneca reported a slightly lower efficacy rate for its COVID-19 vaccine after the results of an American clinical trial were criticized as outdated, raising further questions over the controversial shot and whether it will be approved in the U.S. The company said the shot was 76% effective in its U.S. trial in a statement Thursday, after an independent monitoring board …

Missteps could mar long-term credibility of AstraZeneca shot
3 years, 9 months ago

Missteps could mar long-term credibility of AstraZeneca shot

Associated Press  

LONDON — AstraZeneca’s repeated missteps in reporting vaccine data coupled with a blood clot scare could do lasting damage to the credibility of a shot that is the linchpin in the global strategy to stop the coronavirus pandemic, potentially even undermining vaccine confidence more broadly, experts say. The latest stumble for the vaccine came Tuesday, when American officials issued an …

It’s been declared safe and effective. But missteps dog AstraZeneca’s COVID vaccine
3 years, 9 months ago

It’s been declared safe and effective. But missteps dog AstraZeneca’s COVID vaccine

LA Times  

AstraZeneca’s release of encouraging data Monday about its COVID-19 vaccine from its U.S. trial raised hopes that the drug company could bury doubts about the shot and put a troubled rollout behind it. But hours later, U.S. officials issued an unusual statement expressing concern that the company had included “outdated information” from its study and that it may have provided …

AstraZeneca COVID-19 Vaccine Trial Data Questioned By Safety Board
3 years, 9 months ago

AstraZeneca COVID-19 Vaccine Trial Data Questioned By Safety Board

NPR  

AstraZeneca COVID-19 Vaccine Trial Data Questioned By Safety Board Enlarge this image toggle caption Matthias Schrader/AP Matthias Schrader/AP A safety board overseeing AstraZeneca's COVID-19 vaccine trial is raising concerns about the company's data. If the pharmaceutical company did include outdated information from that trial, that could provide an "incomplete view of the efficacy data," the NIAID said. The pharmaceutical company …

AstraZeneca may have used outdated info in Covid-19 vaccine trial, says US
3 years, 9 months ago

AstraZeneca may have used outdated info in Covid-19 vaccine trial, says US

India Today  

Results from a US trial of AstraZeneca's Covid-19 vaccine may have included "outdated information" and that could mean the company provided an incomplete view of efficacy data, American federal health officials said early Tuesday. AstraZeneca reported Monday that its Covid-19 vaccine provided strong protection among adults of all ages in a long-anticipated US study, a finding that some experts hoped …

AstraZeneca vaccine: Independent review board raises concerns about trial data
3 years, 9 months ago

AstraZeneca vaccine: Independent review board raises concerns about trial data

CNN  

CNN — In an unusual statement released early Tuesday, the National Institute of Allergy and Infectious Diseases said the independent board that reviews data from multiple Covid-19 vaccine candidates has raised concerns about AstraZeneca’s announcement of efficacy data from its vaccine trial. “The DSMB expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided …

AstraZeneca vaccine trial results may have included outdated info, U.S. officials say
3 years, 9 months ago

AstraZeneca vaccine trial results may have included outdated info, U.S. officials say

LA Times  

AstraZeneca may have included “outdated information” in touting the effectiveness of its COVID-19 vaccine in a U.S. study, federal health officials said Tuesday in an unusual public rift that could further erode confidence in the shot. But shortly after midnight, the National Institutes of Health issued a statement saying the independent monitors that oversee the study had “expressed concern that …

U.S. data shows AstraZeneca’s vaccine is effective for all ages
3 years, 9 months ago

U.S. data shows AstraZeneca’s vaccine is effective for all ages

The Hindu  

A phase 3 trial of the AstraZeneca vaccine candidate in the United States has revealed an efficacy of 79%, when both doses were administered 4 weeks apart. ‘No safety concerns’ The U.S. trial, which recruited over 32,000 volunteers across all age groups, showed that the vaccine is 79% effective against symptomatic COVID-19, and 100% effective against severe, or critical symptomatic …

European Trust In AstraZeneca Vaccine Falls, Opinion Poll Says
3 years, 9 months ago

European Trust In AstraZeneca Vaccine Falls, Opinion Poll Says

News 18  

Fewer Europeans trust the AstraZeneca COVID-19 vaccine after several countries reported side-effects, such as blood clots, an opinion poll by YouGov showed on Monday, even though scientific studies have found it is safe and effective. An increased number of French, German, Italian, and Spanish adults said they considered the vaccine unsafe, YouGov found, although faith in other vaccines by Pfizer …

AstraZeneca shot 79 percent effective in US, Chile, Peru trials
3 years, 9 months ago

AstraZeneca shot 79 percent effective in US, Chile, Peru trials

Al Jazeera  

The data paves the way for the company, which has been embroiled in a safety row in the EU, to apply for US approval for its COVID-19 jab. AstraZeneca says the COVID-19 vaccine it developed in cooperation with Oxford University was 79-percent effective in preventing symptomatic illness a large trial in the United States, Chile and Peru, paving the way …

AstraZeneca vaccine is 79% effective against symptomatic Covid-19, company says
3 years, 9 months ago

AstraZeneca vaccine is 79% effective against symptomatic Covid-19, company says

CNN  

CNN — AstraZeneca’s Covid-19 vaccine showed 79% efficacy against symptomatic disease and 100% efficacy against severe disease and hospitalization in a new, US-based clinical trial, the company said Monday. Evans called previous assertions that the vaccine may be ineffective in older ages”totally unjustified.” The Oxford-AstraZeneca vaccine became the subject of controversy earlier in the month when a number of European …

Discover Related